Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 501

1.

Catastrophic health expenditure and impoverishment in households of persons with depression: a cross-sectional, comparative study in rural Ethiopia.

Hailemichael Y, Hanlon C, Tirfessa K, Docrat S, Alem A, Medhin G, Lund C, Chisholm D, Fekadu A, Hailemariam D.

BMC Public Health. 2019 Jul 11;19(1):930. doi: 10.1186/s12889-019-7239-6.

2.

Catastrophic out-of-pocket payments for households of people with severe mental disorder: a comparative study in rural Ethiopia.

Hailemichael Y, Hailemariam D, Tirfessa K, Docrat S, Alem A, Medhin G, Lund C, Chisholm D, Fekadu A, Hanlon C.

Int J Ment Health Syst. 2019 Jun 1;13:39. doi: 10.1186/s13033-019-0294-7. eCollection 2019.

3.

Sustainable financing mechanisms for strengthening mental health systems in Nigeria.

Abdulmalik J, Olayiwola S, Docrat S, Lund C, Chisholm D, Gureje O.

Int J Ment Health Syst. 2019 May 31;13:38. doi: 10.1186/s13033-019-0293-8. eCollection 2019.

4.

Photoactivated cell-killing involving a low molecular weight, donor-acceptor diphenylacetylene.

Chisholm DR, Lamb R, Pallett T, Affleck V, Holden C, Marrison J, O'Toole P, Ashton PD, Newling K, Steffen A, Nelson AK, Mahler C, Valentine R, Blacker TS, Bain AJ, Girkin J, Marder TB, Whiting A, Ambler CA.

Chem Sci. 2019 Mar 21;10(17):4673-4683. doi: 10.1039/c9sc00199a. eCollection 2019 May 7.

5.

Effect of a stepped-care intervention delivered by lay health workers on major depressive disorder among primary care patients in Nigeria (STEPCARE): a cluster-randomised controlled trial.

Gureje O, Oladeji BD, Montgomery AA, Bello T, Kola L, Ojagbemi A, Chisholm D, Araya R.

Lancet Glob Health. 2019 Jul;7(7):e951-e960. doi: 10.1016/S2214-109X(19)30148-2. Epub 2019 May 13.

6.

Longitudinal Changes in Insulin Resistance in Normal Weight, Overweight and Obese Individuals.

Tang A, Coster ACF, Tonks KT, Heilbronn LK, Pocock N, Purtell L, Govendir M, Blythe J, Zhang J, Xu A, Chisholm DJ, Johnson NA, Greenfield JR, Samocha-Bonet D.

J Clin Med. 2019 May 8;8(5). pii: E623. doi: 10.3390/jcm8050623.

7.

Genomic and non-genomic pathways are both crucial for peak induction of neurite outgrowth by retinoids.

Khatib T, Marini P, Nunna S, Chisholm DR, Whiting A, Redfern C, Greig IR, McCaffery P.

Cell Commun Signal. 2019 May 2;17(1):40. doi: 10.1186/s12964-019-0352-4.

8.

CYP26A1 gene promoter is a useful tool for reporting RAR-mediated retinoid activity.

Zolfaghari R, Mattie FJ, Wei CH, Chisholm DR, Whiting A, Ross AC.

Anal Biochem. 2019 Jul 15;577:98-109. doi: 10.1016/j.ab.2019.04.022. Epub 2019 Apr 27.

PMID:
31039331
9.

A Bioluminescence Reporter Assay for Retinoic Acid Control of Translation of the GluR1 Subunit of the AMPA Glutamate Receptor.

Khatib T, Whiting A, Chisholm DR, Redfern C, Müller B, McCaffery P.

Mol Neurobiol. 2019 Apr 10. doi: 10.1007/s12035-019-1571-9. [Epub ahead of print]

PMID:
30972628
10.

Moving towards universal health coverage for mental disorders in Ethiopia.

Hanlon C, Alem A, Lund C, Hailemariam D, Assefa E, Giorgis TW, Chisholm D.

Int J Ment Health Syst. 2019 Feb 25;13:11. doi: 10.1186/s13033-019-0268-9. eCollection 2019.

11.

High- versus low-intensity interventions for perinatal depression delivered by non-specialist primary maternal care providers in Nigeria: cluster randomised controlled trial (the EXPONATE trial).

Gureje O, Oladeji BD, Montgomery AA, Araya R, Bello T, Chisholm D, Groleau D, Kirmayer LJ, Kola L, Olley LB, Tan W, Zelkowitz P.

Br J Psychiatry. 2019 Feb 15:1-8. doi: 10.1192/bjp.2019.4. [Epub ahead of print]

PMID:
30767826
12.

Fluorescent Retinoic Acid Analogues as Probes for Biochemical and Intracellular Characterization of Retinoid Signaling Pathways.

Chisholm DR, Tomlinson CWE, Zhou GL, Holden C, Affleck V, Lamb R, Newling K, Ashton P, Valentine R, Redfern C, Erostyák J, Makkai G, Ambler CA, Whiting A, Pohl E.

ACS Chem Biol. 2019 Mar 15;14(3):369-377. doi: 10.1021/acschembio.8b00916. Epub 2019 Feb 13.

PMID:
30707838
13.

Sustainable financing options for mental health care in South Africa: findings from a situation analysis and key informant interviews.

Docrat S, Lund C, Chisholm D.

Int J Ment Health Syst. 2019 Jan 21;13:4. doi: 10.1186/s13033-019-0260-4. eCollection 2019.

14.

Novel Fluorescence Competition Assay for Retinoic Acid Binding Proteins.

Tomlinson CWE, Chisholm DR, Valentine R, Whiting A, Pohl E.

ACS Med Chem Lett. 2018 Nov 9;9(12):1297-1300. doi: 10.1021/acsmedchemlett.8b00420. eCollection 2018 Dec 13.

15.

Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome.

Maxted AP, Dalrymple RA, Chisholm D, McColl J, Tse Y, Christian MT, Reynolds BC.

Pediatr Nephrol. 2019 May;34(5):855-863. doi: 10.1007/s00467-018-4172-3. Epub 2018 Dec 18.

16.

Potential strategies for sustainably financing mental health care in Uganda.

Ssebunnya J, Kangere S, Mugisha J, Docrat S, Chisholm D, Lund C, Kigozi F.

Int J Ment Health Syst. 2018 Dec 5;12:74. doi: 10.1186/s13033-018-0252-9. eCollection 2018.

17.

Cost-effectiveness of strategies to prevent road traffic injuries in eastern sub-Saharan Africa and Southeast Asia: new results from WHO-CHOICE.

Ralaidovy AH, Bachani AM, Lauer JA, Lai T, Chisholm D.

Cost Eff Resour Alloc. 2018 Nov 20;16:59. doi: 10.1186/s12962-018-0161-4. eCollection 2018.

18.

Tandem fluorescence and Raman (fluoRaman) characterisation of a novel photosensitiser in colorectal cancer cell line SW480.

Gala de Pablo J, Chisholm DR, Steffen A, Nelson AK, Mahler C, Marder TB, Peyman SA, Girkin JM, Ambler CA, Whiting A, Evans SD.

Analyst. 2018 Dec 3;143(24):6113-6120. doi: 10.1039/c8an01461b.

19.

Integrated care for people with long-term mental and physical health conditions in low-income and middle-income countries.

Thornicroft G, Ahuja S, Barber S, Chisholm D, Collins PY, Docrat S, Fairall L, Lempp H, Niaz U, Ngo V, Patel V, Petersen I, Prince M, Semrau M, Unützer J, Yueqin H, Zhang S.

Lancet Psychiatry. 2019 Feb;6(2):174-186. doi: 10.1016/S2215-0366(18)30298-0. Epub 2018 Nov 15. Review.

PMID:
30449711
20.

The Lancet Commission on global mental health and sustainable development.

Patel V, Saxena S, Lund C, Thornicroft G, Baingana F, Bolton P, Chisholm D, Collins PY, Cooper JL, Eaton J, Herrman H, Herzallah MM, Huang Y, Jordans MJD, Kleinman A, Medina-Mora ME, Morgan E, Niaz U, Omigbodun O, Prince M, Rahman A, Saraceno B, Sarkar BK, De Silva M, Singh I, Stein DJ, Sunkel C, UnÜtzer J.

Lancet. 2018 Oct 27;392(10157):1553-1598. doi: 10.1016/S0140-6736(18)31612-X. Epub 2018 Oct 9. Review. No abstract available. Erratum in: Lancet. 2018 Oct 27;392(10157):1518.

PMID:
30314863
21.

Universal Health Coverage and Intersectoral Action for Health.

Jamison DT, Alwan A, Mock CN, Nugent R, Watkins DA, Adeyi O, Anand S, Atun R, Bertozzi S, Bhutta Z, Binagwaho A, Black R, blecher M, Bloom BR, Brouwer E, Bundy DAP, Chisholm D, Cieza A, Cullen M, Danforth K, Silva Nd, Debas HT, Donkor P, Dua T, Fleming KA, Gallivan M, Garcia P, Gawande A, Gaziano T, Gelband H, Glass R, Glassman A, Gray G, Habte D, Holmes KK, Horton S, Hutton G, Jha P, Knaul F, Kobusingye O, Krakauer E, Kruk ME, Lachmann P, Laxminarayan R, Levin C, Looi LM, Madhav N, Mahmoud A, Mbanya JC, Measham AR, Medina-Mora ME, Medlin C, Mills A, Mills JA, Montoya J, Norheim O, Olson Z, Omokhodion F, Oppenheim B, Ord T, Patel V, Patton GC, Peabody J, Prabhakaran D, Qi J, Reynolds T, Ruacan S, Sankaranarayanan R, Sepúlveda J, Skolnik R, Smith KR, Temmerman M, Tollman S, Verguet S, Walker D, Walker N, Wu Y, Zhao K.

In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R, editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 27. Chapter 1.

22.

Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.

Salamone JM, Lucas W, Brundage SB, Holloway JN, Stahl SM, Carbine NE, London M, Greenwood N, Goyes R, Chisholm DC, Price E, Carlin R, Winarsky S, Baker KB, Maues J, Shajahan-Haq AN.

Cancer Res. 2018 Oct 15;78(20):5723-5728. doi: 10.1158/0008-5472.CAN-18-1600. Epub 2018 Aug 17. Review.

23.

Are the "Best Buys" for Alcohol Control Still Valid? An Update on the Comparative Cost-Effectiveness of Alcohol Control Strategies at the Global Level.

Chisholm D, Moro D, Bertram M, Pretorius C, Gmel G, Shield K, Rehm J.

J Stud Alcohol Drugs. 2018 Jul;79(4):514-522.

PMID:
30079865
24.

Development of quality indicators for mental healthcare in the Danube region.

Lehmann I, Chisholm D, Hinkov H, Höschl C, Kapócs G, Kurimay T, Lecic-Tosevski D, Nakov V, Réthelyi JM, Winkler P, Zielasek J, Gaebel W.

Psychiatr Danub. 2018 Jun;30(2):197-206. doi: 10.24869/psyd.2018.197.

25.

Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services.

Bertram MY, Sweeny K, Lauer JA, Chisholm D, Sheehan P, Rasmussen B, Upreti SR, Dixit LP, George K, Deane S.

Lancet. 2018 May 19;391(10134):2071-2078. doi: 10.1016/S0140-6736(18)30665-2. Epub 2018 Apr 5. Review. Erratum in: Lancet. 2018 Apr 5;:.

PMID:
29627159
26.

The cost of child and adolescent mental health services.

Skokauskas N, Lavelle TA, Munir K, Sampaio F, Nystrand C, McCrone P, McDaid D, Chisholm D, Byford S, Ganguli P, Feldman I, Belfer M.

Lancet Psychiatry. 2018 Apr;5(4):299-300. doi: 10.1016/S2215-0366(18)30089-0. No abstract available.

PMID:
29580605
27.

Collaborative care for the detection and management of depression among adults receiving antiretroviral therapy in South Africa: study protocol for the CobALT randomised controlled trial.

Fairall L, Petersen I, Zani B, Folb N, Georgeu-Pepper D, Selohilwe O, Petrus R, Mntambo N, Bhana A, Lombard C, Bachmann M, Lund C, Hanass-Hancock J, Chisholm D, McCrone P, Carmona S, Gaziano T, Levitt N, Kathree T, Thornicroft G; CobALT research team.

Trials. 2018 Mar 22;19(1):193. doi: 10.1186/s13063-018-2517-7.

28.

Probing biological activity through structural modelling of ligand-receptor interactions of 2,4-disubstituted thiazole retinoids.

Haffez H, Chisholm DR, Tatum NJ, Valentine R, Redfern C, Pohl E, Whiting A, Przyborski S.

Bioorg Med Chem. 2018 May 1;26(8):1560-1572. doi: 10.1016/j.bmc.2018.02.002. Epub 2018 Feb 10.

29.

Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition.

Jamison DT, Alwan A, Mock CN, Nugent R, Watkins D, Adeyi O, Anand S, Atun R, Bertozzi S, Bhutta Z, Binagwaho A, Black R, Blecher M, Bloom BR, Brouwer E, Bundy DAP, Chisholm D, Cieza A, Cullen M, Danforth K, de Silva N, Debas HT, Donkor P, Dua T, Fleming KA, Gallivan M, Garcia PJ, Gawande A, Gaziano T, Gelband H, Glass R, Glassman A, Gray G, Habte D, Holmes KK, Horton S, Hutton G, Jha P, Knaul FM, Kobusingye O, Krakauer EL, Kruk ME, Lachmann P, Laxminarayan R, Levin C, Looi LM, Madhav N, Mahmoud A, Mbanya JC, Measham A, Medina-Mora ME, Medlin C, Mills A, Mills JA, Montoya J, Norheim O, Olson Z, Omokhodion F, Oppenheim B, Ord T, Patel V, Patton GC, Peabody J, Prabhakaran D, Qi J, Reynolds T, Ruacan S, Sankaranarayanan R, Sepúlveda J, Skolnik R, Smith KR, Temmerman M, Tollman S, Verguet S, Walker DG, Walker N, Wu Y, Zhao K.

Lancet. 2018 Mar 17;391(10125):1108-1120. doi: 10.1016/S0140-6736(17)32906-9. Epub 2017 Nov 25. Review.

30.

Strengthening mental health system governance in six low- and middle-income countries in Africa and South Asia: challenges, needs and potential strategies.

Petersen I, Marais D, Abdulmalik J, Ahuja S, Alem A, Chisholm D, Egbe C, Gureje O, Hanlon C, Lund C, Shidhaye R, Jordans M, Kigozi F, Mugisha J, Upadhaya N, Thornicroft G.

Health Policy Plan. 2017 Jun 1;32(5):699-709. doi: 10.1093/heapol/czx014.

31.

Muscle Sympathetic Nerve Activity Is Associated with Liver Insulin Sensitivity in Obese Non-Diabetic Men.

Chen DL, Brown R, Liess C, Poljak A, Xu A, Zhang J, Trenell M, Jenkins A, Chisholm D, Samocha-Bonet D, Macefield VG, Greenfield JR.

Front Physiol. 2017 Feb 28;8:101. doi: 10.3389/fphys.2017.00101. eCollection 2017.

32.

Mental health service availability and delivery at the global level: an analysis by countries' income level from WHO's Mental Health Atlas 2014.

Lora A, Hanna F, Chisholm D.

Epidemiol Psychiatr Sci. 2017 Mar 13:1-12. doi: 10.1017/S2045796017000075. [Epub ahead of print]

PMID:
28287062
33.

The molecular basis of the interactions between synthetic retinoic acid analogues and the retinoic acid receptors.

Haffez H, Chisholm DR, Valentine R, Pohl E, Redfern C, Whiting A.

Medchemcomm. 2017 Jan 20;8(3):578-592. doi: 10.1039/c6md00680a. eCollection 2017 Mar 1.

34.

Health Gains and Financial Protection Provided by the Ethiopian Mental Health Strategy: an Extended Cost-Effectiveness Analysis.

Johansson KA, Strand KB, Fekadu A, Chisholm D.

Health Policy Plan. 2017 Apr 1;32(3):376-383. doi: 10.1093/heapol/czw134.

35.

Practical synthetic strategies towards lipophilic 6-iodotetrahydroquinolines and -dihydroquinolines.

Chisholm DR, Zhou GL, Pohl E, Valentine R, Whiting A.

Beilstein J Org Chem. 2016 Aug 16;12:1851-1862. eCollection 2016.

36.

Scaling-up services for psychosis, depression and epilepsy in sub-Saharan Africa and South Asia: development and application of a mental health systems planning tool (OneHealth).

Chisholm D, Heslin M, Docrat S, Nanda S, Shidhaye R, Upadhaya N, Jordans M, Abdulmalik J, Olayiwola S, Gureje O, Kizza D, Mugisha J, Kigozi F, Hanlon C, Adugna M, Sanders R, Pretorius C, Thornicroft G, Lund C.

Epidemiol Psychiatr Sci. 2017 Jun;26(3):234-244. doi: 10.1017/S2045796016000408. Epub 2016 Sep 19.

PMID:
27641074
37.

Conjugate Addition of 3-Buytn-2-one to Anilines in Ethanol: Alkene Geometric Insights through In Situ FTIR Monitoring.

Chisholm DR, Valentine R, Pohl E, Whiting A.

J Org Chem. 2016 Sep 2;81(17):7557-65. doi: 10.1021/acs.joc.6b01110. Epub 2016 Aug 10.

PMID:
27467234
38.

An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance.

Raykar N, Nigam A, Chisholm D.

Cost Eff Resour Alloc. 2016 Jul 8;14:9. doi: 10.1186/s12962-016-0058-z. eCollection 2016.

39.

Scaling-up of treatment of depression and anxiety - Authors' reply.

Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, Saxena S.

Lancet Psychiatry. 2016 Jul;3(7):603-4. doi: 10.1016/S2215-0366(16)30131-6. No abstract available.

PMID:
27371983
40.

Time for mental health to come out of the shadows.

Kleinman A, Estrin GL, Usmani S, Chisholm D, Marquez PV, Evans TG, Saxena S.

Lancet. 2016 Jun 4;387(10035):2274-2275. doi: 10.1016/S0140-6736(16)30655-9. No abstract available.

PMID:
27302252
41.

Global Priorities for Addressing the Burden of Mental, Neurological, and Substance Use Disorders.

Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, Ferrari AJ, Hyman S, Laxminarayan R, Levin C, Lund C, Medina-Mora ME, Petersen I, Scott JG, Shidhaye R, Vijayakumar L, Thornicroft G, Whiteford HA on behalf of the DCP MNS authors group.

In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 1.

42.

Universal Health Coverage for Mental, Neurological, and Substance Use Disorders: An Extended Cost-Effectiveness Analysis.

Chisholm D, Johansson KA, Raykar N, Megiddo I, Nigam A, Strand KB, Colson A, Fekadu A, Verguet S.

In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 13.

43.

Population and Community Platform Interventions.

Petersen I, Evans-Lacko S, Semrau M, Barry M, Chisholm D, Gronholm P, Egbe CO, Thornicroft G.

In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 10.

44.

Health Care Platform Interventions.

Shidhaye R, Lund C, Chisholm D.

In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 11.

45.

Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders.

Levin C, Chisholm D.

In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 12.

46.

Indicators for routine monitoring of effective mental healthcare coverage in low- and middle-income settings: a Delphi study.

Jordans MJ, Chisholm D, Semrau M, Upadhaya N, Abdulmalik J, Ahuja S, Alem A, Hanlon C, Kigozi F, Mugisha J, Petersen I, Shidhaye R, Lund C, Thornicroft G, Gureje O.

Health Policy Plan. 2016 Oct;31(8):1100-6. doi: 10.1093/heapol/czw040. Epub 2016 Apr 23.

PMID:
27107294
47.

Scaling-up treatment of depression and anxiety: a global return on investment analysis.

Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, Saxena S.

Lancet Psychiatry. 2016 May;3(5):415-24. doi: 10.1016/S2215-0366(16)30024-4. Epub 2016 Apr 12.

48.

Promotion, prevention and protection: interventions at the population- and community-levels for mental, neurological and substance use disorders in low- and middle-income countries.

Petersen I, Evans-Lacko S, Semrau M, Barry MM, Chisholm D, Gronholm P, Egbe CO, Thornicroft G.

Int J Ment Health Syst. 2016 Apr 11;10:30. doi: 10.1186/s13033-016-0060-z. eCollection 2016. Review.

49.

Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans.

Tonks KT, Coster AC, Christopher MJ, Chaudhuri R, Xu A, Gagnon-Bartsch J, Chisholm DJ, James DE, Meikle PJ, Greenfield JR, Samocha-Bonet D.

Obesity (Silver Spring). 2016 Apr;24(4):908-16. doi: 10.1002/oby.21448. Epub 2016 Feb 24.

50.

Health and economic benefits of public financing of epilepsy treatment in India: An agent-based simulation model.

Megiddo I, Colson A, Chisholm D, Dua T, Nandi A, Laxminarayan R.

Epilepsia. 2016 Mar;57(3):464-74. doi: 10.1111/epi.13294. Epub 2016 Jan 14.

Supplemental Content

Loading ...
Support Center